UNSPSC 51171830: Batanopride

This classification denotes an antiemetic agent with the molecular formula C17H26ClN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1AT99K728N, chemically known as benzamide, 4-amino-5-chloro-n-(2-(diethylamino)ethyl)-2-(1-methyl-2-oxopropoxy)- but generally known as batanopride, which bears US NIH Compound Identifier 59692. Batanopride most often comes in base and hydrochloride forms. European Medicines Agency schedules Batanopride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06108MIG.

UNSPSC 51171830 Batanopride, a Commodity code, does not map to state and local government procurement activity in the available recent-opportunities data. The three opportunities tagged under this code—offender drug testing services (Collin County, Texas), a pharmacy benefit management information request (Texas HHS Commission), and generic pharmaceutical supply (Minnesota MMCAP cooperative purchasing)—involve pharmaceutical products and services but do not align with batanopride, a selective serotonin reuptake inhibitor medication. The code appears to reflect either a miscataloging error in the state and local procurement systems or a mismatch between the UNSPSC taxonomy and the actual scope of work being solicited.

No substantive state and local procurement activity under UNSPSC 51171830 is evident from the recent record. Business development professionals should verify the accuracy of this code assignment within their target jurisdictions' procurement systems before pursuing opportunities tagged to it, as the current opportunities do not represent demand for batanopride itself.